Zinc-α2-glycoprotein is associated with non-albuminuric chronic kidney disease progression in type 2 diabetes: a retrospective study with 4-year follow-up.
A MohN SeahS LowK AngC F SumT SubramaniamP Y KwanS LeeW E TangJian-Jun LiuPublished in: Diabetic medicine : a journal of the British Diabetic Association (2020)
Plasma zinc-α2-glycoprotein is associated with chronic kidney disease progression, and may serve as a useful early biomarker for predicting non-albuminuric chronic kidney disease progression in type 2 diabetes.